Skip to main content
. 2011 Sep 1;2(5):276–281. doi: 10.4161/sgtp.2.5.17740

Figure 2.

Figure 2

KSR1 attenuates ERK activation in GDC0879, but not PLX4720-treated cells. A549 cells expressing either the pLKO.1 vector or pLKO.1-KSR1 shRNA were treated as indicated for 1 hr. Lysates were analyzed for pERK and tubulin levels. Depletion of KSR1 is also shown.